• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of effective mucosal vaccine against bacterial afferent infectious diseases

Research Project

Project/Area Number 15590395
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Bacteriology (including Mycology)
Research InstitutionNAGOYA CITY UNIVERSITY

Principal Investigator

TANIGUCHI Toru  Nagoya City University, Graduate School of Medical Sciences, Assistant Professor, 大学院・医学研究科, 講師 (00285199)

Co-Investigator(Kenkyū-buntansha) ISAKA Masanori  Nagoya City University, Graduate School of Medical Sciences, Research Associate, 大学院・医学研究科, 助手 (40336673)
IIDA Tetsuya  Osaka University, Research Institute for Microbial Diseases, 微生物病研究所, 助教授 (90221746)
Project Period (FY) 2003 – 2004
Project Status Completed (Fiscal Year 2004)
Budget Amount *help
¥2,700,000 (Direct Cost: ¥2,700,000)
Fiscal Year 2004: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 2003: ¥1,500,000 (Direct Cost: ¥1,500,000)
Keywordsenterotoxigenic Escherichia coli / Vibrio parahaemolyticus / pili / colonization factor / adhesin / thermostable direct hemolvsin / mucosal vaccine / immune response
Research Abstract

For prevention (vaccine) of enterotoxigenic Escherichia coli (ETEC) and Vibrio parahaemolyticus infections, it is important to stimulate the production of mucosal secretory immunoglobulin A (sIgA) for blocking of colonization to intestinal epithelium and neutralizing of toxins. Recombinant cholera toxin B subunit (rCTB) was used as a mucosal adjuvant.
1. Purification of vaccine antigen
Adhesins (CfaE and CofJ) of pilus colonization factor antigens (CFA/I and CFA/III) of ETEC and less hemolytic mutant toxin of thermostable direct hemolysin (mTDH) of V. parahaemolyticus were purified by using His-tag fusion vector (pQE-30Xa).
2. Immune response in experiment animal
Intranasal administration of CfaE or CofJ to BALB/c mice with and without rCTB induced CfaE-and CofJ-specific serum IgG and mucosal immune response (sIgA) in the saliva, the nasal cavity, the lung, the vagina, the small intestine and the feces.
BALB/c mice immunized intranasally with mTDH irrespective of the presence of rCTB showed TDH-specific serum IgG antibody response and mucosal immune response (sIgA), especially in the lung and the small intestine. Moreover, mice immunized could protect against lethal challenge with wild-type TDH.

Report

(3 results)
  • 2004 Annual Research Report   Final Research Report Summary
  • 2003 Annual Research Report
  • Research Products

    (12 results)

All 2005 2004 2003 Other

All Journal Article (10 results) Publications (2 results)

  • [Journal Article] 腸炎ビブリオ耐熱性溶血毒の変異体の経鼻投与による免疫応答の検討2005

    • Author(s)
      松井 秀之
    • Journal Title

      日本細菌学雑誌 60・1

      Pages: 156-156

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine2004

    • Author(s)
      Isaka, Masanori et al.
    • Journal Title

      Vaccine 22

      Pages: 3061-3068

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Effects of recombinant cholera toxin B subunit (rCTB) on cellular immune responses : enhancement of delayed-type hypersensitivity following intranasal co-administration of Mycobacterium bovis-BCG with rCTB2004

    • Author(s)
      Maeyama, Jun-ichi et al.
    • Journal Title

      Microbiology and Immunology 48

      Pages: 457-463

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Cytotoxicity and enterotoxicity of the thermostable direct hemolysin-deletion mutants of Vibrio parahaemolyticus2004

    • Author(s)
      Park, Kwon-Sam et al.
    • Journal Title

      Microbiology and Immunology 48

      Pages: 313-318

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine2004

    • Author(s)
      Isaka Masanori et al.
    • Journal Title

      Vaccine 22 (23/24)

      Pages: 3061-3068

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Effects of recombinant cholera toxin B subunit (rCTB) on cellular immune responses: enhancement of delayed-type hypersensitivity following intranasal co-administration of Mycobacterium bovis-BCG with rCTB2004

    • Author(s)
      Maeyama Jun-ichi et al.
    • Journal Title

      Microbiology and Immunology 48 (6)

      Pages: 457-463

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Cytotoxicity and enterotoxicity of the thermostable direct hemolysin-deletion mutants of Vibrio parahaemolyticus2004

    • Author(s)
      Park Kwon-Sam et al.
    • Journal Title

      Microbiology and Immunology 48 (4)

      Pages: 313-318

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Recombinant cholera toxin B subunit(rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus(DPT) combination vaccine.2004

    • Author(s)
      Isaka, Masanori
    • Journal Title

      Vaccine 22・23-24

      Pages: 3061-3068

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies2003

    • Author(s)
      Yasuda, Yoko et al.
    • Journal Title

      Vaccine 21

      Pages: 2954-2963

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies2003

    • Author(s)
      Yasuda Yoko et al.
    • Journal Title

      Vaccine 21(21/22)

      Pages: 2954-2963

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Publications] Yasuda, Yoko: "Frequent nasal administrations of recombinant cholera toxin B subunit(rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies"Vaccine. 21・21-22. 2954-2963 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Isaka, Masanori: "Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant"Vaccine. 21・11-12. 1165-1173 (2003)

    • Related Report
      2003 Annual Research Report

URL: 

Published: 2003-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi